Skip to main content

Roll Call Vote #105 · 112th Congress · Session 2 · May 24, 2012, 12:08 PM (ET)

On the Amendment S.Amdt. 2111 to S. 3187 (No short title on file)

Amendment S.Amdt. 2111 (To provide substantial savings in health care costs to the Federal government and consumers by fostering competition among generic pharmaceutical manufacturers and ensuring that anti-competitive "pay-for-delay" settlements between brand-name and generic pharmaceutical manufacturers do not block generic drugs from entering the market.)

Amendment Rejected (28-67, 3/5 majority required)
28 Yea
67 Nay
← Vote #104 Vote #106 →

How the Parties Voted

Democrat 31 senators

15 Yea / 15 Nay

1 not voting or present

Majority position: Yea

Republican 29 senators

3 Yea / 24 Nay

2 not voting or present

Majority position: Nay

Independent Democrat 1 senator

0 Yea / 1 Nay

Majority position: Nay

Independent 1 senator

0 Yea / 1 Nay

Majority position: Nay

Crossed Party Lines

Full Roll Call: How Every Senator Voted

Yea 28

Nay 67

Not Voting 5

Source: Official U.S. Senate roll call vote data (senate.gov ↗).